Clinical data | |
---|---|
Other names | 17β-((5-Hydroxypentyl)amino)estradiol; 17β-estra-1,3,5(10)-trien-3-ol |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C23H35NO2 |
Molar mass | 357.538 g·mol−1 |
3D model (JSmol) | |
| |
|
Pentolame, also known as 17β-((5-hydroxypentyl)amino)estradiol is a synthetic, steroidal estrogen and a 17β-aminoestrogen with anticoagulant effects that was first described in 1993 and was never marketed.[1][2][3]